HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:- -

Open:- -

Low:- -

Close:- -

52wk High:- -

52wk Low:- -

Shares:- -

HK Float Shares:- -

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

PS:- -

Loading ...

Overview Company News Filings

Changchun High-Tech Industry (000661.SZ): GenSci142 Capsule Receives Approval for Domestic Clinical Trial Application

Changchun High-Tech (000661.SZ) Plans Hong Kong IPO, CSRC Requests Additional Disclosures on Fund Usage

Changchun High-Tech (000661.SZ): GenSci134 Injection Receives Approval for Domestic Clinical Trial Application

Changchun High-Tech: Jinbeixin Achieves Strong Sales Since Mid-July Launch After June 2025 Approval

Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) Reports Q3 Results: Net Profit Attributable to Shareholders Drops 58.23% YoY to RMB1.165 Billion

Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ): Clinical Trial Approval for GenSci139 Injectable Drug

Profit Plummets 42% and Expenses Soar 46%: Challenges Faced by Changchun High-Tech’s Hong Kong Listing

Changchun High-Tech (000661.SZ): Clinical Trial Application for GenSci143 Received

Former Star Stock Changchun High-Tech Plans to Go Public in Hong Kong

Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) Subsidiary Receives Approval for Trivalent Influenza Virus Split Vaccine (BK-01 Adjuvant) Clinical Trial Application

Former "Northeast Pharma Giant" Changchun High-Tech Applies for Hong Kong Listing Amid Performance Decline and Market Value Shrinkage of Over 160 Billion Yuan

Changchun High-Tech Industry Bets on Desensitization Market Amid Volume-Based Procurement Pressure and Intensifying Competition

Changchun High-Tech Industry's Subsidiary Receives Approval for Tibolone Tablets in China

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/91272/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"91272","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91272\",,,,,undefined,":{"symbol":"91272","market":"HK","secType":"STK","nameCN":"CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.","latestPrice":0,"timestamp":1764921600000,"preClose":0,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0,"latestTime":"12-05 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":0,"adr":0,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0,"lotSize":0,"spreadScale":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"91272\",,,,,undefined,":{"symbol":"91272","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"--","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/91272\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"91272\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"91272\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"91272\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174264473","title":"Changchun High-Tech Industry (000661.SZ): GenSci142 Capsule Receives Approval for Domestic Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1174264473","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174264473?lang=en_us&edition=fundamental","pubTime":"2025-11-27 17:00","pubTimestamp":1764234029,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) announced that its subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd. (\"Jinsai Pharma\"), has received the \"Drug Clinical Trial Approval...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0057","BK0188","BK0028","BK0075","91272","BK0046","000661"],"gpt_icon":0},{"id":"1143591750","title":"Changchun High-Tech (000661.SZ) Plans Hong Kong IPO, CSRC Requests Additional Disclosures on Fund Usage","url":"https://stock-news.laohu8.com/highlight/detail?id=1143591750","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143591750?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:04","pubTimestamp":1763121863,"startTime":"0","endTime":"0","summary":"On November 14, China Securities Regulatory Commission (CSRC) released supplementary material requirements for overseas listings (November 10-14, 2025). The CSRC's international department disclosed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000661","91272","BK0046","BK0057","BK0188","BK0028","BK0239","BK0075"],"gpt_icon":0},{"id":"1137543318","title":"Changchun High-Tech (000661.SZ): GenSci134 Injection Receives Approval for Domestic Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1137543318","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137543318?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:04","pubTimestamp":1762167854,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) announced that its subsidiary, Jinsai Pharmaceutical Co., Ltd., has received the \"Drug Clinical Trial Approval Notice\" issued by the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91272","BK0046","000661","BK0028","BK0188","BK0239","BK0057","BK0075"],"gpt_icon":0},{"id":"1126490787","title":"Changchun High-Tech: Jinbeixin Achieves Strong Sales Since Mid-July Launch After June 2025 Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1126490787","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126490787?lang=en_us&edition=fundamental","pubTime":"2025-10-31 17:30","pubTimestamp":1761903032,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co., Ltd. announced on October 31 that Jinbeixin, approved in late June 2025, commenced sales in mid-July and has demonstrated robust performance. The product...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0188","000661","BK0046","BK0239","BK0075","91272","BK0057"],"gpt_icon":0},{"id":"1118925011","title":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) Reports Q3 Results: Net Profit Attributable to Shareholders Drops 58.23% YoY to RMB1.165 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1118925011","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118925011?lang=en_us&edition=fundamental","pubTime":"2025-10-30 23:48","pubTimestamp":1761839291,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) released its third-quarter report for 2025. During the first three quarters, the company achieved operating revenue of RMB9.807 billion,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0188","91272","BK0046","000661","BK0057","BK0028","BK0075"],"gpt_icon":0},{"id":"1113752779","title":"Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ): Clinical Trial Approval for GenSci139 Injectable Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1113752779","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113752779?lang=en_us&edition=fundamental","pubTime":"2025-10-20 18:54","pubTimestamp":1760957666,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) announced that its subsidiary, Changchun JinSai Pharmaceutical Co., Ltd. (\"JinSai Pharmaceutical\"), has received the \"Drug Clinical Trial...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91272","BK0188","BK0028","000661","BK0075","BK0046","BK0239","BK0057"],"gpt_icon":0},{"id":"1149063078","title":"Profit Plummets 42% and Expenses Soar 46%: Challenges Faced by Changchun High-Tech’s Hong Kong Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1149063078","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149063078?lang=en_us&edition=fundamental","pubTime":"2025-10-20 09:21","pubTimestamp":1760923273,"startTime":"0","endTime":"0","summary":"When the Hong Kong prospectus of Changchun High-Tech Industry (Group) Co., Ltd. appeared on the Hong Kong Stock Exchange's disclosure website, the market did not respond as positively as anticipated....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0075","91272","BK0046","BK0188","BK0239","BK0057","BK0028","000661"],"gpt_icon":0},{"id":"1108472628","title":"Changchun High-Tech (000661.SZ): Clinical Trial Application for GenSci143 Received","url":"https://stock-news.laohu8.com/highlight/detail?id=1108472628","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108472628?lang=en_us&edition=fundamental","pubTime":"2025-10-17 16:54","pubTimestamp":1760691265,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) announced that its subsidiary, Changchun JinSai Pharmaceutical Co., Ltd. (“JinSai Pharmaceutical”), has received written notification from...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000661","BK0057","91272","BK0188","BK0075","BK0239","BK0046","BK0028"],"gpt_icon":0},{"id":"1165570526","title":"Former Star Stock Changchun High-Tech Plans to Go Public in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=1165570526","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165570526?lang=en_us&edition=fundamental","pubTime":"2025-10-15 18:50","pubTimestamp":1760525454,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co., Ltd., once a star stock, has recently submitted an application for overseas listing (H-shares) to the Hong Kong Stock Exchange. Since 2021, the stock price...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","BK0057","BK0188","000661","91272","BK0028","BK0075","BK0239"],"gpt_icon":0},{"id":"1198166958","title":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) Subsidiary Receives Approval for Trivalent Influenza Virus Split Vaccine (BK-01 Adjuvant) Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1198166958","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198166958?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:14","pubTimestamp":1760354071,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) announced that its subsidiary Becker Biologics has received the \"Drug Clinical Trial Approval Notice\" from the National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU1201861249.SGD","BK0075","BK","BK0057","LU0130102774.USD","LU0648001328.SGD","BK0028","LU1571399168.USD","BK4588","91272","LU1699723380.USD","BK0188","159646","BK4559","BK4135","LU0130517989.USD","BK0046","LU0477156953.USD","000661","BK0239","BK4585"],"gpt_icon":0},{"id":"1125952835","title":"Former \"Northeast Pharma Giant\" Changchun High-Tech Applies for Hong Kong Listing Amid Performance Decline and Market Value Shrinkage of Over 160 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1125952835","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125952835?lang=en_us&edition=fundamental","pubTime":"2025-10-11 21:01","pubTimestamp":1760187697,"startTime":"0","endTime":"0","summary":"Once valued at over 200 billion yuan, the former \"Northeast pharmaceutical giant\" now faces nearly halved net profits. Under the shadow of declining growth hormone benefits, Changchun High-Tech...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0057","BK0188","BK0028","BK0075","91272","BK0046","000661"],"gpt_icon":0},{"id":"1179122496","title":"Changchun High-Tech Industry Bets on Desensitization Market Amid Volume-Based Procurement Pressure and Intensifying Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=1179122496","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179122496?lang=en_us&edition=fundamental","pubTime":"2025-10-08 16:54","pubTimestamp":1759913656,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SH), dubbed the \"Northeast Pharma Moutai,\" continued its revenue and profit decline trend in the first half of this year, extending last year's...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","000661","BK0028","91272","BK0057","BK0075","BK0188","BK0046"],"gpt_icon":0},{"id":"1144018702","title":"Changchun High-Tech Industry's Subsidiary Receives Approval for Tibolone Tablets in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1144018702","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144018702?lang=en_us&edition=fundamental","pubTime":"2025-09-29 16:26","pubTimestamp":1759134414,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) announced that its subsidiary Changchun GeneScience Pharmaceuticals Co., Ltd. (GeneScience Pharmaceuticals) has recently received a Drug...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0057","BK0188","BK0046","BK0075","000661","BK0239","BK0028","91272"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}